Palisade Bio (PALI) EBITDA Margin Growth (5y) (2016 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 8.49 Mn |
| Dec 31, 2020 | 1.40 Mn |
| Sep 30, 2020 | 13.28 Mn |
| Jun 30, 2020 | 13.99 Mn |
| Mar 31, 2020 | 3.23 Mn |
| Dec 31, 2019 | 1.80 Mn |
| Sep 30, 2019 | 1.14 Mn |
| Jun 30, 2019 | 5.20 Mn |
| Mar 31, 2019 | -39,371.00 |
| Dec 31, 2018 | 9.76 Mn |
| Sep 30, 2018 | 7.21 Mn |
| Jun 30, 2018 | 12.92 Mn |
| Mar 31, 2018 | -8.31 Mn |
| Dec 31, 2017 | 10.78 Mn |
| Sep 30, 2017 | -387,942.00 |
| Jun 30, 2017 | -18.29 Mn |
| Mar 31, 2017 | -30.11 Mn |
| Dec 31, 2016 | -6.08 Mn |
| Sep 30, 2016 | -20.57 Mn |